Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae
Authors:
- Dirkie van RensburgDRDirkie van Rensburg
- Charles FogartyCFCharles Fogarty
- María Cristina De SalvoMSMaría Cristina De Salvo
- Manickam RangarajuMRManickam Rangaraju
- Roomi NusratRNRoomi Nusrat
- 31 October 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Infection
- Vol. 51 (3) , 201-205
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsJournal of Antimicrobial Chemotherapy, 2003
- Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactamsJournal of Antimicrobial Chemotherapy, 2003
- Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 2002
- Surveillance of resistance in bacteria causing community‐acquired respiratory tract infectionsClinical Microbiology and Infection, 2002
- Macrolide Resistance Among Invasive Streptococcus pneumoniae IsolatesJAMA, 2001
- Guidelines for the Management of Adults with Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and ClarithromycinClinical Infectious Diseases, 2000
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Management of Community-Acquired Pneumonia in the Era of Pneumococcal ResistanceArchives of internal medicine (1960), 2000
- Breakthrough Sepsis in Macrolide-Resistant Pneumococcal InfectionThe Pediatric Infectious Disease Journal, 1996